These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 9070312)

  • 1. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
    González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
    Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation.
    Carrasco-Marín E; Alvarez-Domínguez C; Leyva-Cobián F
    Eur J Immunol; 1994 Sep; 24(9):2031-9. PubMed ID: 8088323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
    Guéry JC; Adorini L
    J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional differences and complementation between dendritic cells and macrophages in T-cell activation.
    Guidos C; Sinha AA; Lee KC
    Immunology; 1987 Jul; 61(3):269-76. PubMed ID: 2956179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
    Böhm W; Schirmbeck R; Elbe A; Melber K; Diminky D; Kraal G; van Rooijen N; Barenholz Y; Reimann J
    J Immunol; 1995 Oct; 155(7):3313-21. PubMed ID: 7561024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
    Brocke P; Armandola E; Garbi N; Hämmerling GJ
    Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells.
    Weber DA; Buck LB; Delohery TM; Agostino N; Pernis B
    J Mol Cell Immunol; 1990; 4(5):255-66; discussion 266-8. PubMed ID: 2169757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells.
    Kleijmeer MJ; Ossevoort MA; van Veen CJ; van Hellemond JJ; Neefjes JJ; Kast WM; Melief CJ; Geuze HJ
    J Immunol; 1995 Jun; 154(11):5715-24. PubMed ID: 7751623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathymic presentation by dendritic cells and macrophages: their role in selecting T cells with specificity for internal and external nominal antigen.
    Zöller M
    Immunology; 1991 Nov; 74(3):407-13. PubMed ID: 1722772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
    Brazil MI; Weiss S; Stockinger B
    Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
    Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
    Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
    Matousek MP; Nedrud JG; Harding CV
    J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
    Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
    J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
    Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
    Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
    Grant CF; Ali R; Povey S; Stockinger B
    Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.